| Financial Year |
March 31 2023 |
| Monetary Funds |
750,382,345.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
350,000,000.00 |
| Accounts Receivable |
2,881,348,028.94 |
| Advances to Suppliers |
1,352,974,525.65 |
| Other Receivables |
103,251,524.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,306,472,277.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,882,579.25 |
| Total Current Assets |
6,779,311,281.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
23,899,278.34 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
149,531,306.58 |
| Under-construction Projects |
61,902,800.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
431,290,100.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,626,560.58 |
| Deferred Income Tax Assets |
49,174,653.96 |
| Other Non-Current Assets |
403,308,055.01 |
| Sub-Total of Non-Current Assets |
1,149,006,894.69 |
| Total Assets |
7,928,318,176.29 |
| Short-Term Loans |
470,375,654.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
512,000,000.00 |
| Accounts Payable |
1,689,934,601.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,251,374.92 |
| Taxes Payable |
187,586,016.37 |
| Interest Payable |
4,378,050.00 |
| Dividend Payable |
-- |
| Other payables |
125,267,796.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,631,530.36 |
| Other Current Liabilities |
424,956,588.90 |
| Sub-Total of Current Liabilities |
4,076,836,994.92 |
| Long-term Loans |
660,755,380.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
114,013,982.33 |
| Deferred Income Tax Liabilities |
43,970,629.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
838,350,182.69 |
| Total Liabilities |
4,915,187,177.61 |
| Paid-In Capital(Or Share Stock) |
783,025,760.00 |
| Capital Surplus |
904,151,934.01 |
| Surplus Reserve |
177,962,461.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,068,043,052.24 |
| Minority Stockholder's Interest |
111,527,485.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,901,603,513.46 |
| Owner's Equity（Stockholder's Equity） |
3,013,130,998.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,928,318,176.29 |
